Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?

[1]  D. Penson.  The Power and the Peril of Large Administrative Databases. , 2015, The Journal of urology.

[2]  David C. Miller,et al.  Variation in prostate cancer care. , 2015, JAMA.

[3]  P. Stattin,et al.  MP42-10 EXPANDING USE OF ACTIVE SURVEILLANCE: DATA FROM THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN , 2015 .

[4]  Sam S. Chang,et al.  Increasing use of observation among men at low risk for prostate cancer mortality. , 2015, The Journal of urology.

[5]  Robert J Volk,et al.  Physician variation in management of low-risk prostate cancer: a population-based cohort study. , 2014, JAMA internal medicine.

[6]  David C. Miller,et al.  Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology , 2014 .

[7]  Jean M. Mitchell.  Urologists' use of intensity-modulated radiation therapy for prostate cancer. , 2013, The New England journal of medicine.

[8]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[9]  B. Durbin-Johnson,et al.  Active surveillance for prostate cancer compared with immediate treatment , 2012, Cancer.

[10]  David C. Miller,et al.  Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer. , 2011, The Journal of urology.

[11]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[12]  R. Beyth,et al.  Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials , 2010, BMJ : British Medical Journal.

[13]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[14]  D Andrew Loblaw,et al.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. , 2010, The Journal of urology.

[15]  Matthew R Cooperberg,et al.  Time trends and local variation in primary treatment of localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Timothy M. Pawlik,et al.  Limitations of Claims and Registry Data in Surgical Oncology Research , 2008, Annals of Surgical Oncology.

[17]  P. Walsh,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2003, The Journal of urology.

[18]  E. McGlynn,et al.  The quality of health care delivered to adults in the United States. , 2003, The New England journal of medicine.

[19]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[20]  Peter C Albertsen,et al.  Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom. , 2002, Surgical oncology.

[21]  M. O’mahony.  Screening for prostate cancer. , 1998, Hospital medicine.

[22]  A. D'Amico,et al.  Prostate cancer, version 2.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[23]  P. Maté Mate.  [Radical prostatectomy versus observation for localized prostate cancer]. , 2013, Revista clinica espanola.